Geczik, Ashley M.
Ferris, Jennifer S.
Terry, Mary Beth
Andrulis, Irene L.
Buys, Saundra S.
Daly, Mary B.
Hopper, John L.
John, Esther M.
Kurian, Allison W.
Southey, Melissa C.
Liao, Yuyan
Genkinger, Jeanine M. http://orcid.org/0000-0002-8438-0412
Funding for this research was provided by:
National Cancer Institute (TL1TR001875, U01 CA164920)
Article History
Received: 7 November 2021
Accepted: 8 June 2022
First Online: 2 July 2022
Declarations
:
: The authors have no competing interests.
: This study was performed in accordance with the Declaration of Helsinki. All participants in the BCFR provided written informed consent before participation. Human research ethics committees at the participating institutions granted ethics approval for the six sites of the BCFR:Northern California—Cancer Prevention Institute of California, Institutional Review Board (2001–033) and Stanford University School of Medicine, Institutional Review Board (45842) New York—Columbia University Medical Center, Institutional Review Board (AAA7794) Philadelphia—Fox Chase Cancer Center, Institutional Review Board (95–009) Utah—Huntsman Cancer Institute, University of Utah, Institutional Review Board (00004965) Ontario—Mount Sinai Hospital Research Ethics Board (#02–0076-U) and University Health Network Research Ethics Board (#96-U107-CE) Australia—University of Melbourne, Human Ethics Sub-Committee (1441420.1).